Clinical Trial Update: An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Ranger DEB for below-the-knee angioplasty in patients with critical limb ischemia and peripheral artery disease; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Ranger DEB

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lower Limb Ischemia, Peripheral Vascular Diseases | Phase 2, Phase 3 | Status: UNKNOWN